Navigation Links
New Report Just Published: World Prostate Cancer Therapeutics Market Report
Date:7/7/2009

ug Approvals and Clinical Studies II-53 Debiopharm Unveils Results of Phase III Study of Trelstar in Prostate Cancer Treatment II-53 Algeta to Start Clinical Study of Alpharadin in HRPC II-53 Ferring Receives FDA Approval for Degarelix in Prostate Cancer II-53 Isis and OncoGenex Reveals Positive results of OGX-011 Molecule in HRPC II-53 Antisoma Completes Phase 2 Study of ASA404 in Prostate Cancer II-53 Cougar Conducts Phase I/II Clinical Trials on CB7630 in Patients with Prostate Cancer II-54 Ambrilia Unveils Results of PCK3145 in Patients with Metastatic Prostate Cancer II-54 Peregrine Pharmaceuticals Reveals Pre-Clinical Data on Bavituximab in Prostate Cancer II-54 Cell Genesys Reveals Data of GVAX Immunotherapy for Treatment of Prostate Cancer II-54 Bioponic Phytoceuticals Unveils Pre-Clinical Data on Curecumin(TM) for Prostate Cancer II-55 New Study Reveals Cough Medicine - Noscapine to be Effective in Prostate Cancer II-55 Fosamax(R) Found Effective in Preventing Bone Loss in Prostate Cancer Patients II-55 Genta Unveils Results of Phase II Clinical Trial of Genasense(R) in Prostate Cancer II-55 Cell Therapeutics Reveals Phase 2 Clinical Trial Results of XYOTAX(TM) in Androgen Independent Prostate Cancer Patients II-56 Sanofi-Aventis' Taxotere(R) Enhances Survival in Metastatic Prostate Cancer Patients II-56 NCI Initiates Phase 2 Clinical Trial of Cytogen's QUADRAMET for HRPC II-56 Cleveland BioLabs to Initiate Phase II Clinical Trial for Curaxin in HRPC II-57 NeoRx Begins Clinical Study for Picoplatin in Prostate Cancer II-57 Novacea Starts Phase III Clinical Trial for Treatment of Prostate Cancer II-57 Next Pharmaceuticals' Supplement Nexrutine Help Prevent Prostate Cancer II-57 Antisoma Reveals Results from AS1404 Phase II Clinical Trial in HRPC II-57 Marshall Edward
'/>"/>
SOURCE Reportlinker
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related biology technology :

1. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
2. QMed, Inc. Reports July Medicare SNP Enrollments
3. Phlo Affiliate Reports Expanded Coverage to Oregon Border
4. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
5. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
6. Carrington Reports Second Quarter 2007 Results
7. Avitar Reports Third Quarter Financial Results for Fiscal 2007
8. Response Genetics Reports Second Quarter 2007 Financial Results
9. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
10. Transgenomic, Inc. Reports Second Quarter 2007 Results
11. Pressure BioSciences, Inc. Reports Second Quarter 2007 Financial Results and Provides Business Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... PARIS , July 30, 2014 /PRNewswire/ ... and NYSE: SNY) today announced that the Companies intend ... rare pediatric disease priority review voucher in connection with ... priority review voucher entitles the holder to designate a ... 6-month review from the filing date instead of the ...
(Date:7/30/2014)... , July 30, 2014  The Chicago Bears are ... Academy of Dermatology (Academy) in an effort to raise ... Bears will host free SPOT me™ skin cancer screenings ... at Soldier Field. SPOT me™ is an educational ... the dangers and risks of skin cancer, and encourages ...
(Date:7/30/2014)... July 30, 2014 Sales Horizons, a ... of blended sales training programs for companies engaged in ... programs used by thousands of salespeople over 25 years ... training program can be customized to address the unique ... blended sales training program consists of two ...
(Date:7/30/2014)... BCC Research ( http://www.bccresearch.com ) reveals ... in Industrial Applications , the global market for industrial ... by 2018, registering a five-year compound annual growth rate ... recorded in the detergent enzyme segment with a CAGR ... has influenced almost every sector of industrial activity, ranging ...
Breaking Biology Technology:Regeneron and Sanofi Announce Plan to Use Priority Review Voucher For Alirocumab U.S. FDA Submission 2Regeneron and Sanofi Announce Plan to Use Priority Review Voucher For Alirocumab U.S. FDA Submission 3Regeneron and Sanofi Announce Plan to Use Priority Review Voucher For Alirocumab U.S. FDA Submission 4Regeneron and Sanofi Announce Plan to Use Priority Review Voucher For Alirocumab U.S. FDA Submission 5Regeneron and Sanofi Announce Plan to Use Priority Review Voucher For Alirocumab U.S. FDA Submission 6Chicago Bears Join the American Academy of Dermatology in Fight against Skin Cancer 2Chicago Bears Join the American Academy of Dermatology in Fight against Skin Cancer 3Chicago Bears Join the American Academy of Dermatology in Fight against Skin Cancer 4Sales Horizons Launches New Blended Sales Training Programs to Companies Engaged in Complex B2B Sales 2Sales Horizons Launches New Blended Sales Training Programs to Companies Engaged in Complex B2B Sales 3Global Market for Industrial Enzymes to Reach Nearly $7.1 Billion by 2018; Detergent Enzyme Market to Record Maximum Growth 2Global Market for Industrial Enzymes to Reach Nearly $7.1 Billion by 2018; Detergent Enzyme Market to Record Maximum Growth 3
... INDIANAPOLIS, March 26 A coalition of Indiana,s ... and business joined today to launch Hoosiers Work ... importance of preserving medical innovation. Co-chairs, former ... the Pacers Sports & Entertainment Jim Morris, kicked ...
... Inc. (OTC Bulletin Board: OXBO) today announced that the ... the planned Phase II dose escalation study of Oxycyte(R) ... perfluorocarbon (PFC) therapeutic oxygen carrier. The Israeli sites are ... are excited to be able to participate in this ...
... Distribution Agreement for the Americas -- The Agreement ... ZyGEM,s Growing Line of DNA Extraction Kits -- ... Ideally Suited to Automation and High-Throughput Applications -SOLANA ... 26 ZyGEM Corp. Ltd. and VWR International ...
Cached Biology Technology:Hoosiers Work for Health Highlights Impact of Medical Research and Innovation on Indiana Economy 2Hoosiers Work for Health Highlights Impact of Medical Research and Innovation on Indiana Economy 3Hoosiers Work for Health Highlights Impact of Medical Research and Innovation on Indiana Economy 4Oxygen Biotherapeutics, Inc. Adds Oxycyte TBI Clinical Trial Sites in Israel 2ZyGEM Corp. and VWR International Europe BVBA Sign Agreement to Distribute Breakthrough DNA Extraction Technology in Europe 2ZyGEM Corp. and VWR International Europe BVBA Sign Agreement to Distribute Breakthrough DNA Extraction Technology in Europe 3ZyGEM Corp. and VWR International Europe BVBA Sign Agreement to Distribute Breakthrough DNA Extraction Technology in Europe 4
(Date:7/30/2014)... develop into a multitude of cells types. Researchers would like ... types of mature cells that make up the organs and ... to be long chains of sugars that dangle from proteins ... University of California, San Diego, has created synthetic molecules that ... more easily manipulated to direct the process, they report in ...
(Date:7/30/2014)... high-resolution map of the carbon stocks stored on ... new and improved methodology used to make the ... carbon economies. The new carbon map also ... provides the critical input to studies of deforestation ... enforcement purposes. The technique includes the determination of ...
(Date:7/29/2014)... advanced optical methods and applications for imaging and manipulation ... the neurosciences were the inspiration behind Neurophotonics , ... society for optics and photonics. , The first issue ... the United States, and a special section features articles ... of the impact that optics and photonics will have ...
Breaking Biology News(10 mins):Peru's carbon quantified: Economic and conservation boon 2Peru's carbon quantified: Economic and conservation boon 3SPIE launches Neurophotonics journal with special section on BRAIN Initiative 2SPIE launches Neurophotonics journal with special section on BRAIN Initiative 3
... HealthSystem (NorthShore) and Northwestern University have discovered that fiber ... measure blood levels in the colonic lining (mucosa) in ... colon cancer. The study appears in the ... journal of the American Gastroenterological Association (AGA) Institute. ...
... Sediment in rivers comes from erosion of the landscape as ... Just how much each source contributes to a river ... river is the subject of research by Peter Whiting, ... Taking measure of certain radionuclides found in the soil, including ...
... feather flock together, according to the old adage, and adolescent ... specific gene are more likely to flock to delinquent peers, ... criminologist Kevin M. Beaver. "This research is groundbreaking because ... with delinquent peers is tied up in the genome," said ...
Cached Biology News:Breakthrough optical technology to assess colon cancer risk, accuracy 2Breakthrough optical technology to assess colon cancer risk, accuracy 3Case Western Reserve University project ties soil conservation and river management together 2Study reveals specific gene in adolescent men with delinquent peers 2Study reveals specific gene in adolescent men with delinquent peers 3
Anti-Kusabira Orange Monoclonal Antibody Description: 100 g Research Focus: tag Storage: -20C Shipping Temperature: 4C...
PURA Immunogen: PURA (NP_005850, 183 a.a. ~ 293 a.a) partial recombinant protein with GST tag. Storage: -20 C, Avoid Freeze/Thaw Cycles *Available for distribution in the US only...
Rabbit polyclonal to CAMK 1D beta ( Abpromise for all tested applications). entrezGeneID: 57118 SwissProtID: Q5SQQ7...
Acetyl-Histone H2B (Lys20) Antibody...
Biology Products: